Cardiomyopathy epidemiology and demographics

Cardiomyopathy Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Cardiomyopathy from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Guidelines
2023 ESC Guideline Recommendations
2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy
Case Studies
Case #1
Cardiomyopathy epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Cardiomyopathy epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Cardiomyopathy epidemiology and demographics
CDC on Cardiomyopathy epidemiology and demographics
Cardiomyopathy epidemiology and demographics in the news
Blogs on Cardiomyopathy epidemiology and demographics
Directions to Hospitals Treating Cardiomyopathy
Risk calculators and risk factors for Cardiomyopathy epidemiology and demographics

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

References

• ncidence and prevalence differ based on cause.

• The incidence of DCM has been estimated to be 5-8 cases per 100,000 population, with a prevalence of 36 per 100,000. This could be explained by the incomplete disease expression, which goes unrecognized.

• The prevalence of HCM in the absence of aortic valve disease or systemic hypertension is at least 1:500 of the adult population.

• RCM is much less common than either DCM or HCM in the developed world, but is a frequent cause of death in the tropical countries, primarily because of the high incidence of endomyocardial fibrosis in those regions.